FDA orders safety studies for some asthma drugs – Reuters

FDA orders safety studies for some asthma drugs
Reuters
WASHINGTON (Reuters) – Health regulators have ordered drugmakers to conduct clinical trials involving a total of 53000 patients to test the safety of a controversial class of inhaled asthma drugs that are already on the market.
FDA Drug Safety Communication: FDA requires post-market safety trials for Long Bioscience Technology

all 9 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *